Earum Pharmaceuticals IPO vs Suich Industries IPO

Comparison between Earum Pharmaceuticals IPO and Suich Industries IPO.

IPO Details

Earum Pharmaceuticals IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Suich Industries IPO is a SME Bookbuilding proposed to list at BSE SME.

Issue Size and Price

The total issue size of Earum Pharmaceuticals IPO is up to ₹6.31 Cr whereas the issue size of the Suich Industries IPO is up to ₹29.30 Cr. The final issue price of Earum Pharmaceuticals IPO is ₹36.00 per share and of Suich Industries IPO is ₹75.00 per share.

 Earum Pharmaceuticals IPOSuich Industries IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)₹73.00 per share
Issue Price (Upper)₹75.00 per share
Issue Price (Final)₹36.00 per share₹75.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size3000 shares1600 shares
Fresh Issue Size17,52,000 shares39,07,200 shares
Fresh Issue Size (Amount)up to ₹6.31 Crup to ₹29.30 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total17,52,000 shares39,07,200 shares
Issue Size Total (Amount)up to ₹6.31 Crup to ₹29.30 Cr

IPO Timetable

Earum Pharmaceuticals IPO opens on Jun 21, 2019, while Suich Industries IPO opens on May 30, 2019. The closing date of Earum Pharmaceuticals IPO and Suich Industries IPO is Jun 26, 2019, and Jun 04, 2019, respectively.

 Earum Pharmaceuticals IPOSuich Industries IPO
Issue OpenJun 21, 2019May 30, 2019
Issue CloseJun 26, 2019Jun 04, 2019
Basis Of Allotment (Tentative)Jul 01, 2019Jun 10, 2019
Initiation of Refunds (Tentative)Jul 02, 2019Jun 11, 2019
Credit of Share (Tentative)Jul 03, 2019Jun 12, 2019
Listing date (Tentative)Jul 04, 2019Jun 13, 2019

Financials & KPIs

Earum Pharmaceuticals IPO P/E ratio is , as compared to Suich Industries IPO P/E ratio of .

 Earum Pharmaceuticals IPOSuich Industries IPO
Financials

Company Financials (Restated)

Period Ended31 Dec 201831 Mar 201831 Mar 201731 Mar 2016
Assets27.4120.5311.088.79
Total Income34.5035.8523.6918.63
Profit After Tax0.870.860.160.10
EBITDA1.931.470.310.47
NET Worth5.084.211.531.37
Reserves and Surplus4.773.901.421.26
Total Borrowing7.897.232.081.90
Amount in ₹ Crore

Company Financials (Restated Consolidated)

Period Ended31 Dec 201831 Mar 201831 Mar 201731 Mar 2016
Assets114.18140.4272.7178.96
Total Income140.16202.79144.37106.58
Profit After Tax11.487.435.333.01
EBITDA19.3216.1513.189.96
NET Worth51.7340.2732.8527.52
Reserves and Surplus40.6029.1421.7216.39
Total Borrowing34.4438.4428.2227.31
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)100%95.5%
Promoter Shareholding (Post-Issue)70.04%69.72%
Market Cap₹22.20 Cr.₹114.33 Cr.

Shares Offered

In the Earum Pharmaceuticals IPO Retail Individual Investors (RII) are offered 8,76,000 shares while in Suich Industries IPO retail investors are offered 8,76,000 shares. Qualified Institutional Buyers (QIB) are offered in Earum Pharmaceuticals IPO and in Suich Industries IPO.

 Earum Pharmaceuticals IPOSuich Industries IPO
Market Maker Reservation96,000 shares2,08,000 shares
NII8,76,000 shares19,52,000 shares
RII8,76,000 shares19,55,200 shares
Total17,52,000 shares39,07,200 shares

Bids Received (Subscription)

Earum Pharmaceuticals IPO subscribed 1.60x in total, whereas Suich Industries IPO subscribed 1.39x.

 Earum Pharmaceuticals IPOSuich Industries IPO
NII (times)1.72x1.32x
RII (times)1.48x1.47x
Total (times)1.60x1.39x

Compare with others

Compare:

Earum Pharmaceuticals IPO Vs Suich Industries IPO